BioLineRx Ltd. Cash Flows From Used In Financing Activities
BioLineRx Ltd. (BLRX) reported Cash Flows From Used In Financing Activities of $8.88 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:CashFlowsFromUsedInFinancingActivities · last filed 2026-03-23
| Period end | Cash Flows From Used In Financing Activities 6 month | Cash Flows From Used In Financing Activities 12 month |
|---|---|---|
| 2025-12-31 | $8.88M 20-F · filed 2026-03-23 | |
| 2025-06-30 | $11.05M 6-K · filed 2025-08-14 | |
| 2024-12-31 | $20.66M 20-F · filed 2026-03-23 | |
| 2024-06-30 | $22.98M 6-K · filed 2025-08-14 | |
| 2023-12-31 | $15.06M 20-F · filed 2026-03-23 | |
| 2023-06-30 | -$183.00K 6-K · filed 2024-08-15 | |
| 2022-12-31 | $20.44M 20-F · filed 2025-03-31 | |
| 2022-06-30 | -$1.63M 6-K · filed 2023-08-30 | |
| 2021-12-31 | $57.75M 20-F · filed 2024-03-26 | |
| 2021-06-30 | $56.00M 6-K · filed 2022-08-16 | |
| 2020-12-31 | $17.87M 20-F · filed 2023-03-22 | |
| 2020-06-30 | $11.97M 6-K · filed 2021-08-18 | |
| 2019-12-31 | $19.19M 20-F · filed 2022-03-16 | |
| 2019-06-30 | $15.72M 6-K · filed 2020-08-06 | |
| 2018-12-31 | $13.10M 20-F · filed 2021-02-23 | |
| 2018-06-30 | $2.80M 6-K · filed 2019-08-06 | |
| 2017-12-31 | $38.68M 20-F · filed 2020-03-12 | |
| 2017-06-30 | $28.27M 6-K · filed 2018-08-13 | |
| 2016-12-31 | $2.09M 20-F · filed 2019-03-28 | |
| 2015-12-31 | $29.49M 20-F · filed 2018-03-06 |